Eligi
Med
Ensayos clínicos
Suscripción
Sobre EligiMed
Ensayos Clínicos de Neurología | EligiMed
Ensayos clínicos
8.676 ensayos encontrados
Terminado
Fase 2
ClinicalTrials.gov
A Randomized, Phase 2, Double-blind Study to Evaluate the Efficacy of Dostarlimab Plus Chemotherapy Versus Pembrolizumab Plus Chemotherapy in Metastatic Non-Squamous Non-Small Cell Lung Cancer
INTERVENTIONAL
Inicio: 19 de nov de 2020
ID: NCT04581824
Completado
Fase 3
ClinicalTrials.gov
Effect of γ-Secretase Inhibition on the Progression of Alzheimer's Disease: LY450139 Versus Placebo
INTERVENTIONAL
Inicio: 1 de mar de 2008
ID: NCT00594568
Completado
Fase 3
ClinicalTrials.gov
A Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Efficacy and Safety of CSL112 in Subjects With Acute Coronary Syndrome
INTERVENTIONAL
Inicio: 21 de mar de 2018
ID: NCT03473223
Completado
Fase 4
ClinicalTrials.gov
Phase IV, Multicenter, Open Label, Randomized Study of Rebif® 44 mcg Administered Three Times Per Week by Subcutaneous Injection Compared With Copaxone® 20 mg Administered Daily by Subcutaneous Injection in the Treatment of Relapsing Remitting Multiple Sclerosis
INTERVENTIONAL
Inicio: 16 de feb de 2004
ID: NCT00078338
Completado
Fase 3
ClinicalTrials.gov
A Randomized, Multicenter, Double-blind, Placebo-controlled, Parallel-group Phase 3 Study to Evaluate the Efficacy and Safety of USL255 as Adjunctive Therapy in Patients With Refractory Partial-Onset Seizures
INTERVENTIONAL
Inicio: 1 de may de 2010
ID: NCT01142193
Completado
Fase 3
ClinicalTrials.gov
A Trial Comparing the Effect and Safety of Insulin Degludec Versus Insulin Detemir, Both in Combination With Insulin Aspart, in the Treatment of Pregnant Women With Type 1 Diabetes
INTERVENTIONAL
Inicio: 22 de nov de 2017
ID: NCT03377699
Completado
Fase 3
ClinicalTrials.gov
A Double-blind, Double-dummy, Placebo-controlled, Randomized, Three Parallel Groups Study Comparing the Efficacy, Safety and Tolerability of Pramipexole ER Versus Placebo and Versus Pramipexole IR Administered Orally Over a 26-week Maintenance Phase in Patients With Early Parkinsons Disease (PD).
INTERVENTIONAL
Inicio: 1 de may de 2007
ID: NCT00479401
Reclutando
ClinicalTrials.gov
Assessing the Usefulness of Functional Electrical Stimulation Program on Tibial Nerve for Rehabilitation of Chronic Stroke Patients
INTERVENTIONAL
Inicio: 21 de mar de 2022
ID: NCT05240716
Desconocido
ClinicalTrials.gov
Multifactorial Approach to Dementia. Multicentric Study
OBSERVATIONAL
Inicio: 20 de may de 2023
ID: NCT05923307
Terminado
Fase 3
ClinicalTrials.gov
A Randomized Withdrawal, Active- and Placebo-controlled, Double-blind, Multi-center Phase III Trial Assessing Safety and Efficacy of Oral CG5503 (Tapentadol) Prolonged Release (PR*) in Subjects With Moderate to Severe Chronic Malignant Tumor-related Pain. *Prolonged Release and is the Recommended Nomenclature for Use in the European Union (EU). ER Means Extended Release and is the Recommended Nomenclature for Use in the United States of America (USA). "PR" is Synonymous With "ER" and is Interchangeable.
INTERVENTIONAL
Inicio: 1 de jun de 2007
ID: NCT00505414
Desconocido
ClinicalTrials.gov
Adherence to Low Tidal Volume in the Transition to Spontaneous Ventilation Mode in Patients With Acute Respiratory Failure in ICUs in Latin America
OBSERVATIONAL
Inicio: 12 de jun de 2023
ID: NCT06042036
Completado
ClinicalTrials.gov
Efficacy of Virtual Reality Exercises Using Wii Gaming Technology in STroke Rehabilitation: A Multicentre Randomized Clinical Trial (EVREST Multicentre)
INTERVENTIONAL
Inicio: 1 de jul de 2011
ID: NCT01406912
Terminado
ClinicalTrials.gov
The Use of Laser in the Treatment of Atrophic Vulvovaginitis and Its Consequent Improvement in Sexual Satisfaction
INTERVENTIONAL
Inicio: 20 de sept de 2019
ID: NCT04297319
Completado
Fase 3
ClinicalTrials.gov
A Pivotal, Open-Label, Parallel Study to Evaluate the Safety and Efficacy of Human Insulin Inhalation Powder (HIIP) Compared to Injectable Insulin in Patients With Diabetes and COPD or Asthma
INTERVENTIONAL
Inicio: 1 de ago de 2005
ID: NCT00157339
Terminado
Fase 3
ClinicalTrials.gov
Open-Label, Long Term, Flexible Dose Study Of Safety, Tolerability, And Therapeutic Response In Patients With Parkinson's Disease.
INTERVENTIONAL
Inicio: 1 de ago de 2000
ID: NCT00036205
Completado
Fase 3
ClinicalTrials.gov
Multicenter, Double-blind, Randomized, Parallel-group, Monotherapy, Active-control Study to Determine the Efficacy and Safety of Daclizumab High Yield Process (DAC HYP) Versus Avonex® (Interferon β 1a) in Patients With Relapsing-Remitting Multiple Sclerosis
INTERVENTIONAL
Inicio: 1 de may de 2010
ID: NCT01064401
Por invitación
Fase 3
ClinicalTrials.gov
Long-term Extension Study to Evaluate the Safety and Efficacy of Riliprubart (SAR445088) in Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
INTERVENTIONAL
Inicio: 1 de abr de 2025
ID: NCT06859099
Completado
Fase 3
ClinicalTrials.gov
A Randomized, Multicenter, Multinational, Phase 3B, Open-Label, Parallel-Group Study of Fabrazyme (Agalsidase Beta) in Treatment-Naïve Male Pediatric Patients With Fabry Disease Without Severe Symptoms
INTERVENTIONAL
Inicio: 1 de sept de 2008
ID: NCT00701415
Completado
Fase 3
ClinicalTrials.gov
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Cardiovascular Outcomes Following Treatment With Alogliptin in Addition to Standard of Care in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
INTERVENTIONAL
Inicio: 1 de sept de 2009
ID: NCT00968708
Completado
Fase 2
ClinicalTrials.gov
A Phase I/II, Multicenter, Open-Label, Noncomparative Study of the International Maternal, Pediatric, Adolescent AIDS Clinical Trials (IMPAACT) Group to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of Raltegravir (Isentress, MK-0518) in HIV-1 Infected Children and Adolescents
INTERVENTIONAL
Inicio: 17 de sept de 2007
ID: NCT00485264
Anterior
1
...
33
34
35
...
434
Siguiente
Filtros